A compounding pharmacy in Georgia is recalling all of its sterile products following a Food and Drug Administration investigation that found possible lack of proper sanitation procedures, the FDA said.

Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

Drug maker Genentech is hoping to keep a breast cancer treatment on the market as the Food and Drug Administration considers whether to revoke its approval for the disease, according to published reports.

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...